This inventor holds 1 USPTO granted patent. Top assignees: Beijing Forestry University, Hangzhou Bibau Biotechnology Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Aqin Wang: Pioneering Anti-Inflammatory Peptides
Introduction: Aqin Wang, an innovative inventor based in Zhejiang, China, has made remarkable contributions to the field of biotechnology. With a focus on active peptides derived from egg white proteins, his work has significant implications for anti-inflammatory applications.
Latest Patents: Aqin Wang holds a patent for an "Egg White Protein Anti-Inflammatory Peptide and Application Thereof". This patent highlights his invention of an active peptide, FGPH, which exhibits promising anti-inflammatory properties. Notably, at a concentration of 500 μg/mL, FGPH demonstrates inhibition rates of 64.41% for the inflammatory mediator nitric oxide (NO) and varying percentages for inflammatory factors such as TNF-alpha, IL-6, and IL-1 beta, indicating its potential in combating inflammation.
Career Highlights: Wang's career features significant positions in esteemed organizations such as Hangzhou Bibau Biotechnology Co., Ltd. and Beijing Forestry University. His experiences at these institutions have contributed to his expertise in the research and development of peptide-based solutions.
Collaborations: Throughout his career, Aqin Wang has collaborated with talented individuals, including Difeng Ren and Jun Yu. Working alongside these professionals, he has been able to enhance his research and broaden the scope of applications for his inventions.
Conclusion: Aqin Wang's dedication to advancing the field of active peptides is evident through his innovative patent and impactful career. His work not only showcases the potential of egg white proteins in addressing inflammation but also positions him as a noteworthy inventor in the biotechnology sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile